A large vaccine-derived poliovirus outbreak on Madura island -: Indonesia, 2005

被引:61
作者
Estivariz, Concepcion F. [1 ]
Watkins, Margaret A. [1 ]
Handoko, Darmawali [6 ]
Rusipah, Rusipah [5 ,7 ]
Deshpande, Jagadish [3 ]
Rana, Bardan J. [5 ]
Irawan, Eveline [7 ]
Widhiastuti, Dyah [8 ]
Pallansch, Mark A. [2 ]
Thapa, Arun [4 ]
Imari, Sholah [6 ]
机构
[1] Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA
[3] Indian Council Med Res, Enterovirus Res Ctr, Bombay, Maharashtra, India
[4] World Hlth Org, SE Asia Reg Off, New Delhi, India
[5] World Hlth Org, Indonesia Off, Jakarta, Indonesia
[6] Minist Hlth, Jakarta, Indonesia
[7] Indonesia Natl Polio Lab, Surabaya, Indonesia
[8] Biofarma Natl Polio Lab, Bandung, Indonesia
关键词
D O I
10.1086/525049
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Between June and October 2005, 45 laboratory-confirmed type 1 vaccine-derived poliovirus (VDPV) cases were identified on Madura Island in Indonesia. Genetic sequencing data on VDPV isolates were consistent with replication and circulation for up to similar to 2 years. Concurrent circulation with type 1 wild poliovirus (WPV) enabled comparisons of VDPV and WPV cases and found that clinical and epidemiological features of both were similar. Attack rates for VDPV were as high as those for WPV. Of 41 VDPV case patients with known vaccination status, 25 (61%) had received zero oral polio vaccine (OPV) doses. Low population immunity due to low routine OPV coverage in rural areas and the absence of WPV circulation for more than a decade were major predisposing factors for the emergence of VDPV. Suboptimal surveillance and a limited initial immunization response may have contributed to widespread circulation. Sensitive surveillance and prompt high-quality immunization responses are recommended to prevent the spread of VDPVs.
引用
收藏
页码:347 / 354
页数:8
相关论文
共 28 条
[1]   Vaccine-derived polioviruses [J].
Agol, VI .
BIOLOGICALS, 2006, 34 (02) :103-108
[2]  
Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1093
[3]  
[Anonymous], VACCINES
[4]   Sabin monovalent oral polio vaccines:: Review of past experiences and their potential use after polio eradication [J].
Cáceres, VM ;
Sutter, RW .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (04) :531-541
[5]  
*CDCP, 2005, MMWR-MORBID MORTAL W, V54, P1053
[6]  
Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P145
[7]  
Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P990
[8]  
Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P913
[9]   IDENTIFICATION OF VACCINE-RELATED POLIOVIRUSES BY HYBRIDIZATION WITH SPECIFIC RNA PROBES [J].
DE, L ;
NOTTAY, B ;
YANG, CF ;
HOLLOWAY, BP ;
PALLANSCH, M ;
KEW, O .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (03) :562-571
[10]   Polio eradication: the OPV paradox [J].
Dowdle, WR ;
De Gourville, E ;
Kew, OM ;
Pallansch, MA ;
Wood, DJ .
REVIEWS IN MEDICAL VIROLOGY, 2003, 13 (05) :277-291